(i)This is a combined synopsis/solicitation for commercial items prepared in accordance withFAR Subpart 12.6, as supplemented with additional information included in this notice. Thisannouncement constitutes the only solicitation; proposals are being requested, and a separatewritten solicitation will not be issued.
(ii)The solicitation number is 75N98027Q00062. This solicitation is issued as a Request forQuotation (RFQ). This acquisition is being conducted on a "brand name or equal" basis inaccordance with FAR 11.104 and the provision at FAR 52.211-6, Brand Name or Equal.Offerors proposing an "equal" product must clearly identify the item by brand name (if any),make, and model number, and must provide sufficient descriptive literature and technicaldocumentation to demonstrate that the proposed product meets all salient physical, functional,and performance characteristics listed in Section (v) of this solicitation. Offers of "equal"products that fail to clearly identify the product or that fail to demonstrate compliance with thesalient characteristics may be rejected as non-responsive.
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation forCommercial Products or Commercial Services, and is not expected to exceed the simplifiedacquisition threshold.
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks toaward a firm fixed-price to the responsible offeror whose proposal represents the best value tothe Government.
(iii)The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular March 2026.
